Global Vanadium-48 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Vanadium-48 market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
In 2025, global Vanadium-48 production was approximately 128 grams, with an average global market price of around $12,000 per gram. Total global production capacity for Vanadium-48 reached approximately 240 grams that year, and the industry's average gross profit margin was about 49%. Vanadium-48 is an artificially produced radioactive isotope of the element vanadium, characterized by an atomic number of 23 and a mass number of 48. It is typically produced via nuclear reactions in particle accelerators—for instance, by bombarding a titanium-48 (^48Ti) target with protons (the ^48Ti(p,n)^48V reaction). With a half-life of approximately 15.97 days, V-48 decays primarily through positron emission (β⁺ decay) into titanium-48 (^48Ti), simultaneously releasing high-energy gamma rays; these properties make it highly suitable for use as a tracer in nuclear medicine and for radiometric measurements. Due to its relatively long half-life, detectable positron emission, and significant value in radiolabeling, V-48 is primarily utilized in positron emission tomography (PET) research, radiotracer experiments, nuclear physics studies, and the development of medical imaging technologies. Compared to common short-lived PET isotopes, V-48 offers an extended operational window, facilitating the labeling of complex biomolecules, experimental transport, and long-term animal studies. Currently, V-48 remains a specialized radioisotope with a niche market, serving primarily research institutions, nuclear medicine laboratories, and specialized industrial testing sectors.
The upstream segment of the V-48 industry chain encompasses suppliers of high-purity target materials, manufacturers of particle accelerator equipment, and providers of nuclear reaction systems and radiochemistry laboratory infrastructure. Production typically requires high-purity titanium-48 isotopic targets and the generation of high-energy proton beams via cyclotrons to drive the nuclear reaction. As titanium-48 is a stable isotope, the target material's isotopic abundance, chemical purity, machinability, and thermal stability directly influence production efficiency and final product quality. Upstream equipment includes medical cyclotrons, high-energy beam systems, target station assemblies, automated irradiation systems, and radioactivity detection instruments. The preparation process demands precise control over proton energy, irradiation duration, target thermal management, and subsequent chemical separation procedures, thereby imposing rigorous technical requirements on the production platform. In addition to equipment requirements, significant barriers to entry in the industry chain include the need for radioactive production licenses, radiation protection systems, and specialized nuclear chemistry personnel. The midstream segment of the industry chain primarily comprises Vanadium-48 production units, nuclear medicine research platforms, radioisotope suppliers, and radiopharmaceutical R&D institutions. Midstream enterprises or research institutes utilize cyclotrons to produce Vanadium-48 via nuclear reactions; subsequently, they employ radiochemical processes—such as ion exchange, extraction, precipitation, and chromatographic separation—to remove impurities and obtain high-purity Vanadium-48 products that meet research and application requirements. Downstream applications of Vanadium-48 primarily span nuclear medicine imaging research, PET tracer technology development, life sciences research, nuclear physics experiments, and certain industrial tracing sectors. Because Vanadium-48 emits positrons and generates detectable gamma rays, it is suitable for PET-related experimental research, enabling scientists to analyze the distribution of biomolecules, metabolic processes, and changes in tissue function. In the fields of life sciences and medical research, Vanadium-48 serves as a radioactive tracer nuclide for studying vanadium metabolism, metal ion transport mechanisms, and the behavior of drugs or compounds within the body. Furthermore, its relatively long half-life allows researchers to conduct long-duration experiments, such as animal model studies, pharmacokinetic evaluations, and complex molecular tracking experiments. Beyond the medical field, Vanadium-48 is also utilized in nuclear physics experiments, materials research, and industrial process tracing. In nuclear science research, it is employed for detector calibration, nuclear reaction experiments, and studies involving radioactivity measurements. Looking ahead, driven by advancements in precision medicine and PET technology, as well as the expanding application of radioactive tracer techniques, Vanadium-48 will continue to see steady demand within the market for research-grade radioisotopes; however, the market as a whole will likely retain characteristics of small scale, high technical barriers, and specialized supply.
With the continuous advancement of precision medicine, molecular imaging technologies, and nuclear medicine diagnostic and therapeutic models, Vanadium-48—a radioisotope with positron-emitting properties—is increasingly attracting attention for its application value in PET molecular imaging research. While traditional medical imaging relies primarily on anatomical structural changes to assess disease, modern nuclear medicine focuses more on molecular-level changes during disease progression, creating a greater demand for high-performance tracer nuclides and novel PET probes. With a half-life of approximately 15.97 days and detectable positron and gamma-ray emissions, Vanadium-48 offers a longer experimental window compared to certain short-lived nuclides, making it particularly suitable for labeling complex biomolecules, conducting animal model studies, and performing pharmacokinetic analyses. Consequently, the growing demand for cancer research, the exploration of disease mechanisms, and the development of innovative molecular probes has become a key driver for the expanded application of Vanadium-48.
Secondly, sustained investment in radiopharmaceutical R&D and life sciences research provides long-term growth momentum for the Vanadium-48 market. In recent years, the global radiopharmaceutical industry has expanded rapidly, with radioactive tracer technologies finding increasingly broad application in areas such as cancer diagnosis, drug development evaluation, and biological metabolism studies. Thanks to its excellent tracer capabilities, Vanadium-48 can be used to study elemental metabolic processes, chemical reaction pathways, and the migration of substances within biological systems, offering significant potential in basic medical research and preclinical drug development. It offers unique research value—difficult to replicate with traditional nuclides—particularly in the fields of novel PET tracers, metal coordination compounds, and multifunctional molecular probes. Looking ahead, as pharmaceutical companies, universities, and research institutions increase their investment in precision diagnostic technologies, the demand for Vanadium-48 is expected to maintain steady growth.
Thirdly, advancements in cyclotron technology and the refinement of radioisotope production systems have laid the technical foundation for enhancing the supply capacity of Vanadium-48. Vanadium-48 is primarily produced through nuclear reactions in high-energy particle accelerators, a process that demands high-purity target materials, precise particle beam control, optimized irradiation protocols, and advanced radiochemical separation techniques. In recent years, the increasing number of medical cyclotrons, the development of automated radiochemical equipment, and improvements in isotope separation and purification technologies have continuously boosted the production efficiency of specialized radionuclides. At the same time, the development of regional nuclear medicine centers and research facilities is driving the refinement of supply networks for short-lived radionuclides, thereby enhancing the availability of Vanadium-48. Looking ahead, optimizing production technologies and improving equipment utilization rates will be key strategies for reducing production costs and expanding the scope of application.
Report Scope
This report is a detailed and comprehensive analysis for global Vanadium-48 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Vanadium-48 market size and forecasts, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Vanadium-48 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Vanadium-48 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Vanadium-48 market shares of main players, shipments in revenue ($ Million), sales quantity (Gram), and ASP (US$/g), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vanadium-48
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vanadium-48 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NIDC(DOE IP), Stanford Advanced Materials, Rosatom, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Vanadium-48 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Radionuclidic Purity: 98%-99%
Radionuclidic Purity: ＞99%
Market segment by Chemical Form
Vanadium-48 Chloride
Vanadium-48 Labeled Compounds
Market segment by Purity Grade
Research-grade Vanadium-48
Clinical-grade Vanadium-48
Market segment by Production Method
Cyclotron
Nuclear Facility Production
Market segment by Application
Nuclear Medicine
Scientific Research
Major players covered
NIDC(DOE IP)
Stanford Advanced Materials
Rosatom
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Vanadium-48 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vanadium-48, with price, sales quantity, revenue, and global market share of Vanadium-48 from 2021 to 2026.
Chapter 3, the Vanadium-48 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vanadium-48 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Vanadium-48 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vanadium-48.
Chapter 14 and 15, to describe Vanadium-48 sales channel, distributors, customers, research findings and conclusion.